Jeevan Scientific Technology Ltd

Jeevan Scientific Technology Ltd has delivered a remarkable quarterly performance for March 2026, signalling a significant turnaround in its financial trajectory. The company’s latest results reveal robust revenue growth, substantial margin expansion, and a marked improvement in profitability, positioning it favourably within the healthcare services sector despite broader market headwinds.

Jeevan Scientific Technology Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 29 May 2026. While the rating change occurred on that date, the analysis and financial metrics discussed here reflect the stock's current position as of 31 May 2026, providing investors with the latest insights into the company’s performance and outlook.

Jeevan Scientific Technology Ltd., a micro-cap clinical research organisation, posted a consolidated net profit of ₹1.61 crores in Q4 FY26 (Mar'26), marking a 13.38% sequential improvement from ₹1.42 crores in Q3 FY26. However, this represents a sharp reversal from a loss of ₹1.30 crores in the same quarter last year, translating to a year-on-year decline of 223.85% when measured against the prior year's loss-making base.

Jeevan Scientific Technology Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 13 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 20 May 2026, providing investors with an up-to-date view of its performance and outlook.

Jeevan Scientific Technology Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 13 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 09 May 2026, providing investors with the latest insights into its performance and outlook.

Jeevan Scientific Technology Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 13 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 09 May 2026, providing investors with an up-to-date view of the company’s performance and outlook.

Surging past Rs 93.9 on 7 May 2026, Jeevan Scientific Technology Ltd has marked a significant milestone by reaching a fresh 52-week high. This rally, driven by a confluence of robust technical indicators and sustained price momentum, underscores the stock’s impressive performance over the past year.

Surging past its previous peak, Jeevan Scientific Technology Ltd touched a fresh 52-week high of Rs 86.9 on 6 May 2026, marking a remarkable 108.84% gain over the past year. This milestone comes amid a backdrop of strong technical momentum and sustained price strength across multiple timeframes.

Jeevan Scientific Technology Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 13 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 28 April 2026, providing investors with the latest insights into its performance and outlook.

With a surge to Rs 85.8 on 28 Apr 2026, Jeevan Scientific Technology Ltd has marked a significant milestone by reaching a fresh 52-week high, nearly tripling from its low of Rs 32.85 in the past year. This rally is underpinned by a strong alignment of technical indicators and sustained price momentum, even as the broader market shows signs of cautious trading.

Surging past its previous peak, Jeevan Scientific Technology Ltd touched a new 52-week high of Rs 85.22 on 20 Apr 2026, marking a remarkable rally of over 159% from its 52-week low of Rs 32.85. This milestone comes amid a sustained eight-day winning streak that has propelled the stock well above all key moving averages, signalling robust price momentum.

Jeevan Scientific Technology Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 13 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 17 April 2026, providing investors with an up-to-date perspective on its performance and outlook.

Surging past its previous peaks, Jeevan Scientific Technology Ltd reached a fresh 52-week high of Rs 78.99 on 17 Apr 2026, marking a remarkable 86.19% gain over the past year. This rally has been fuelled by a confluence of strong technical signals and sustained price momentum, even as the broader Sensex index trades slightly lower.

Surging past its previous peaks, Jeevan Scientific Technology Ltd touched a new 52-week high of Rs 78.8 on 16 Apr 2026, marking a remarkable 86.55% gain over the past year. This rally has been fuelled by a confluence of strong technical signals and sustained price momentum, setting the stock apart in the healthcare services sector.

Jeevan Scientific Technology Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 13 Nov 2025. However, the analysis and financial metrics presented here reflect the stock's current position as of 06 April 2026, providing investors with an up-to-date view of its performance and outlook.

Jeevan Scientific Technology Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 13 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 26 March 2026, providing investors with an up-to-date perspective on its performance and outlook.

Jeevan Scientific Technology Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 13 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 15 March 2026, providing investors with an up-to-date view of the company’s performance and outlook.